Koo YX - Search Results

1

Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis.

Koo YX, Tay M, Teh YE, Teng D, Tan DS, Tan IB, Tai DW, Quek R, Tao M, Lim ST. Koo YX, et al. Ann Hematol. 2011 Oct;90(10):1219-23. doi: 10.1007/s00277-011-1241-0. Epub 2011 Apr 26. Ann Hematol. 2011. PMID: 21520001

2

Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre- and post-rituximab.

Tai WM, Chung J, Tang PL, Koo YX, Hou X, Tay KW, Quek R, Tao M, Lim ST. Tai WM, et al. Among authors: koo yx. Ann Hematol. 2011 Jul;90(7):809-18. doi: 10.1007/s00277-010-1150-7. Epub 2011 Jan 13. Ann Hematol. 2011. PMID: 21229246

3

Hepatitis B virus reactivation in a patient with resolved hepatitis B virus infection receiving maintenance rituximab for malignant B-cell lymphoma.

Koo YX, Tan DS, Tan IB, Tao M, Lim ST. Koo YX, et al. Ann Intern Med. 2009 May 5;150(9):655-6. doi: 10.7326/0003-4819-150-9-200905050-00024. Ann Intern Med. 2009. PMID: 19414854 No abstract available.

4

Hepatitis B virus reactivation and role of antiviral prophylaxis in lymphoma patients with past hepatitis B virus infection who are receiving chemoimmunotherapy.

Koo YX, Tan DS, Tan IB, Tao M, Chow WC, Lim ST. Koo YX, et al. Cancer. 2010 Jan 1;116(1):115-21. doi: 10.1002/cncr.24742. Cancer. 2010. PMID: 19899164 Free article.

5

Primary mediastinal large B-cell lymphoma: optimal therapy and prognostic factors in 41 consecutive Asian patients.

Tai WM, Quah D, Yap SP, Tan SH, Tang T, Tay KW, Koo YX, Tao M, Quek R, Lim ST. Tai WM, et al. Among authors: koo yx. Leuk Lymphoma. 2011 Apr;52(4):604-12. doi: 10.3109/10428194.2010.550073. Epub 2011 Jan 24. Leuk Lymphoma. 2011. PMID: 21261504

6

Effect of concomitant statin, metformin, or aspirin on rituximab treatment for diffuse large B-cell lymphoma.

Koo YX, Tan DS, Tan IB, Tai DW, Ha T, Ong WS, Quek R, Tao M, Lim ST. Koo YX, et al. Leuk Lymphoma. 2011 Aug;52(8):1509-16. doi: 10.3109/10428194.2011.574752. Epub 2011 Jun 10. Leuk Lymphoma. 2011. PMID: 21651435

7

Risk of hepatitis B virus reactivation in patients who are hepatitis B surface antigen negative/antibody to hepatitis B core antigen positive and the role of routine antiviral prophylaxis.

Koo YX, Tan DS, Tan BH, Quek R, Tao M, Lim ST. Koo YX, et al. J Clin Oncol. 2009 May 20;27(15):2570-1; author reply 2571-2. doi: 10.1200/JCO.2009.21.9352. Epub 2009 Apr 13. J Clin Oncol. 2009. PMID: 19364951 No abstract available.

8

"Anti-HBc alone" in human immunodeficiency virus-positive and immuno-suppressed lymphoma patients.

Koo YX, Tan DS, Tan IB, Quek R, Tao M, Lim ST. Koo YX, et al. World J Gastroenterol. 2009 Aug 14;15(30):3834-5. doi: 10.3748/wjg.15.3834. World J Gastroenterol. 2009. PMID: 19673031 Free PMC article.

9

Use of rituximab in combination with high-dose methotrexate in the treatment of primary central nervous system lymphoma in a mycophenolate mofetil treated patient with lupus nephritis.

Lai GG, Koo YX, Tao M, Tan TT, Lim ST. Lai GG, et al. Among authors: koo yx. Acta Oncol. 2011 Jan;50(1):144-5. doi: 10.3109/0284186X.2010.504231. Epub 2010 Jul 29. Acta Oncol. 2011. PMID: 20670084 No abstract available.

10

Blood microRNAs in low or no risk ischemic stroke patients.

Tan JR, Tan KS, Koo YX, Yong FL, Wang CW, Armugam A, Jeyaseelan K. Tan JR, et al. Among authors: koo yx. Int J Mol Sci. 2013 Jan 22;14(1):2072-84. doi: 10.3390/ijms14012072. Int J Mol Sci. 2013. PMID: 23340648 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters